The diagnostic assessment of canine lymphoma: implications for treatment

Dorothee Bienzle; William Vernau

doi:10.1016/j.cll.2010.10.001

The diagnostic assessment of canine lymphoma: implications for treatment

Clin Lab Med. 2011 Mar;31(1):21-39. doi: 10.1016/j.cll.2010.10.001.

Authors

Dorothee Bienzle¹, William Vernau

Affiliation

¹ Department of Pathobiology, University of Guelph, Ontario, Canada. dbienzle@uoguelph.ca

PMID: 21295720
DOI: 10.1016/j.cll.2010.10.001

Abstract

Lymphoma in dogs is a heterogeneous cancer with highly variable prognosis. Many types of canine lymphoma have similar counterparts in the World Health Organization classification of human lymphoid tumors. The most common variant of canine lymphoma is diffuse large B-cell lymphoma, which, if treated with multiagent chemotherapy, has a survival time of approximately 12 months. T-cell lymphomas are more heterogeneous and high- and low-grade variants are common, which necessitates classification beyond B- versus T-cell lineage.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Dog Diseases / pathology*
Dog Diseases / therapy
Dogs
Lymphoma / pathology
Lymphoma / therapy
Lymphoma / veterinary*
Prognosis